For more than 60 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance analytical and diagnostic systems explore life and materials at molecular, cellular and microscopic levels in the applied, molecular and pharmaceutical research areas. Our mission is to partner with scientist to shorten time-to-market with confidence, by gaining qualitative and quantitative insights into molecular structure and dynamics with our mass spectrometry and magnetic resonance solutions.

Bruker’s mass spectrometry solutions aim at helping BioPharma scientists get fast answers for their project teams.

From advanced research solutions for drug discovery, translational omics sciences to drug substance characterization, Bruker MS workflows offer unique capabilities to solve complex analytical challenges. Find out about the latest developments for biologics characterization:

• Detection and quantification of HCPs in 15 min with dia-PASEF better informs downstream process development
• Improved sensitivity with the VIP-HESI source allows more sensitive detection of host cell proteins and RNAs
• Next generation top-down sequencing on timsTOF fleX complements the previous CCS-aware peptide mapping workflows